Some have raised the concern that currently this legislation would only allow Health Canada the power to recall a therapeutic product if it presents a serious or imminent risk of injury to health. In the case of Alesse, for instance, where the drug was simply ineffective or a placebo, that was not how Health Canada interpreted it. They didn't consider that a serious adverse health consequence. They deemed that a lifestyle impact.
I go back to my question. Do you feel as though this legislation gives you broad enough powers to act in the interests of Canadian patients and consumer safety?